Citations

Showing 10 of 108119 citations.

Prognosis of hospitalized patients with cirrhosis and acute kidney disease
Wong, Florence , García–Tsao, Guadalupe , Reddy, K. Rajender , O’Leary, Jacqueline G. , Kamath, Patrick S. , Tandon, Puneeta , Vargas, Hugo E. , Biggins, Scott W. , Fallon, Michael B. , Thuluvath, Paul J. , Maliakkal, Benedict, Subramanian, Ram, Bajaj, Jasmohan S. , Thuluvath, Paul J , Tandon, Puneeta , Wong, Florence , Vargas, Hugo E , Lai, Jennifer C. , Thacker, Leroy R.

Mayo Clinic

Liver International | January 13, 2022 | Volume: 42 | Issue: 4 | Pages: 896-904

10.1111/liv.15154 | PMID 35023264 Get It

AbstractBackgroundThe prognosis of acute kidney disease (AKD), defined as a glomerular filtration rate of <60 ml/min/1.73 m2 or a rise in serum creatinine (sCr) of <50% for <3 months, is not clearly known.AimTo study the prevalence, predictive factors and clinical outcomes in hospitalized cirrhotic patients with AKD.MethodsThe North American Consortium for the Study of End‐Stage Liver Disease prospectively enrolled hospitalized decompensated cirrhotic patients. Patients were separated into those with normal renal function (controls or C), AKD or stage 1 AKI as their worst renal dysfunction per International Club of Ascites definition and compared. Parameters assessed included demographics, laboratory data, haemodynamics, renal and patient outcomes.Results1244 patients with cirrhosis and ascites (C: 704 or 57%; AKD: 176 or 14%; stage 1 AKI: 364 or 29%) with similar demographics were enrolled. AKD patients had similar baseline sCr but higher hospital admission in the previous 6 months, and higher peak sCr, compared to controls, with their peak sCr being lower than that in stage 1 AKI patients (all P < .0001). The in‐hospital and 30‐day survival for AKD patients were intermediary between that for controls and stage 1 AKI patients (96% vs 91% vs 86%, P < .0001). The strongest predictors for AKD development while in hospital were the presence of a second infection (OR: 2.44) and diabetes (OR: 1.53).ConclusionsPatients with AKD had intermediate outcomes between stage 1 AKI and controls. AKD patients, especially those with diabetes and a second infection, need careful monitoring and prompt treatment for AKD to prevent negative outcomes.
Are convalescent plasma stocks collected during former COVID‐19 waves still effective against current SARS‐CoV‐2 variants?
Focosi, Daniele , Joyner, Michael J. , Franchini, Massimo , Joyner, Michael J , Focosi, Daniele , Franchini, Massimo , Casadevall, Arturo

Mayo Clinic

Vox Sanguinis | January 13, 2022 | Volume: 117 | Issue: 5 | Pages: 641-646

10.1111/vox.13239 | PMID 35023163 Get It

AbstractCOVID‐19 convalescent plasma (CCP) was among the few frontline therapies used to treat COVID‐19. After large randomized controlled trials (RCTs) relying on late use in hospitalized patients and/or low antibody titres failed to meet their predefined primary endpoint, the infectious disease community reduced usage of CCP in favour of monoclonal antibodies. Consequently, there are CCP stocks at most transfusion centres worldwide, although scattered usage continues. Further, better designed RCTs are also being launched. The urgent question here is: should we use CCP units collected months before given the largely changed viral variant landscape? We review here in vitro evidence that discourages usage of such CCP units against Delta and other variants of concern. CCP collections should be continued in order to update the armamentarium of therapeutics against vaccine breakthrough infections or in unvaccinated patients and is especially relevant in next‐generation RCTs.
Integrating self‐assessment into feedback for emergency medicine residents
Hellmich, Thomas , Sandefur, Benjamin J. , Colletti, James E., Homme, James L. , Thomas, Jenna , Sandefur, Benjamin, Colletti, James , Mullan, Aidan, Homme, James, Mullan, Aidan F.

Mayo Clinic

AEM Education and Training | January 13, 2022 | Volume: 6 | Issue: 1 | Pages: No page available

10.1002/aet2.10721 | PMID 35155973 Get It

AbstractBackgroundIn 2013 the Accreditation Council for Graduate Medical Education (ACGME) introduced “Milestones” designed to nationally standardize the assessment of resident physicians. Previous studies compare resident self‐assessment on milestones to faculty assessment, with varying degrees of agreement, but integration of self‐assessment into the formative feedback process has not yet been directly studied. This study uses a conceptual framework of self‐determination theory, integrated with concepts from adult learning theory, to compare the perception of the feedback quality given in semiannual reviews before and after the incorporation of resident self‐assessment into the feedback process.MethodsThis was an interventional study conducted in a single emergency medicine residency program at a major academic hospital over 1 calendar year. Residents first engaged in a semiannual review without self‐assessment. At subsequent semiannual reviews, residents completed a Milestone‐based self‐assessment that was provided to the faculty member assigned to conduct their semiannual review. Residents and faculty completed surveys rating perception of feedback quality. Two‐sided Wilcoxon signed‐rank tests were used in comparison analysis.ResultsOne resident did not self‐assess prior to the semiannual review and was excluded leaving 25 paired surveys for analysis. Residents found feedback after the self‐assessment more actionable (p = 0.013), insightful (p = 0.010), and better overall (p = 0.025). Similarly, faculty felt the feedback they provided was more actionable (p < 0.001), more insightful (p < 0.001), and better communicated (p < 0.001); led to improved resident understanding of milestones (p < 0.001); and were overall more satisfied (p < 0.001). Free‐text comments explore pre‐ and postintervention perceptions of feedback.ConclusionsIntegration of self‐assessment into semiannual reviews improves perception of feedback given to residents as perceived by both residents and faculty. Although limited by sample size, the results are promising for a simple, evidence‐based intervention to improve feedback during an existing mandated feedback opportunity.
C Proteins: Controllers of Orderly Paramyxovirus Replication and of the Innate Immune Response
Siering, Oliver, Cattaneo, Roberto , Pfaller, Christian K. , Cattaneo, Roberto , Pfaller, Christian K

Mayo Clinic

Viruses | January 12, 2022 | Volume: 14 | Issue: 1 | Pages: 137

10.3390/v14010137 | PMID 35062341 Get It

Particles of many paramyxoviruses include small amounts of proteins with a molecular weight of about 20 kDa. These proteins, termed “C”, are basic, have low amino acid homology and some secondary structure conservation. C proteins are encoded in alternative reading frames of the phosphoprotein gene. Some viruses express nested sets of C proteins that exert their functions in different locations: In the nucleus, they interfere with cellular transcription factors that elicit innate immune responses; in the cytoplasm, they associate with viral ribonucleocapsids and control polymerase processivity and orderly replication, thereby minimizing the activation of innate immunity. In addition, certain C proteins can directly bind to, and interfere with the function of, several cytoplasmic proteins required for interferon induction, interferon signaling and inflammation. Some C proteins are also required for efficient virus particle assembly and budding. C-deficient viruses can be grown in certain transformed cell lines but are not pathogenic in natural hosts. C proteins affect the same host functions as other phosphoprotein gene-encoded proteins named V but use different strategies for this purpose. Multiple independent systems to counteract host defenses may ensure efficient immune evasion and facilitate virus adaptation to new hosts and tissue environments.
Prevalence and Amounts of Common Ingredients Found in Energy Drinks and Shots
Jagim, Andrew R. , Barakat, Abdelrahman , Erickson, Jacob L. , Carvalho, Victoria , Khurelbaatar, Chinguun, Camic, Clayton L., Kerksick, Chad M. , Harty, Patrick S , Barakat, Abdelrahman R, Jagim, Andrew R , Kerksick, Chad M , Harty, Patrick S.

Mayo Clinic

Nutrients | January 12, 2022 | Volume: 14 | Issue: 2 | Pages: 314

10.3390/nu14020314 | PMID 35057494 Get It

Background: Energy drinks are one of the most popular packaged beverage products consumed within the United States (US). Energy drinks are considered a functional beverage, a category that also includes sports drinks and nutraceutical beverages. Purpose: The focus of the current study was to examine the nutrition fact panels of the top selling commercially available energy drink and energy shot products within the US to characterize common ingredient profiles to help establish a standard definition and ingredient profile of energy drinks and energy shots for consumers, health care practitioners, and researchers. Methods: The top 75 commercially available energy drinks and shots were identified and compiled from multiple commercial retail websites as of September 2021. For the purpose of this study, an energy drink must have met the following criteria: (A) marketed as an energy drink; (B) purported to improve energy, focus, or alertness; (C) not sold as a dietary supplement (no supplement fact panels); (D) manufactured as a pre-packaged and ready-to-drink beverage; and (E) contains at least three of (1) caffeine, (2) B-vitamins, (3) sugar, (4) taurine, (5) creatine, (6) quercetin, (7) guarana, (8) ginseng, (9) coenzyme Q10, or (10) branched chain amino acids. Energy shots must have met similar criteria to be included: (A) marketed as an energy shot; (B) purported to improve energy, focus, or alertness; (C) sold as a dietary supplement; (D) manufactured as a pre-packaged beverage with a small volume (<3.5 mL); and (E) contains at least three of the ingredients stated above. Results: Twenty energy shots and fifty-five energy drinks were included in this analysis. The number of ingredients per product (mean ± SD) was 18.2 ± 5.7, with 15 products containing proprietary blends with undisclosed ingredient amounts. The relative prevalence and average amounts of the top ingredients were as follows: caffeine (100%; 174.4 ± 81.1 mg), vitamin B6 (72%; 366.9 ± 648.1 percent daily value (%DV)), vitamin B3 (67%; 121.44 ± 69.9% DV), vitamin B12 (67%; 5244.5 ± 10,474.6% DV), vitamin B5 (37.3%; 113.6 ± 76.6% DV), and taurine (37.3%; amounts undisclosed). Conclusions: Our findings suggest a high prevalence of caffeine and B-vitamins in these energy products, with many of the formulations containing well above the recommended daily value of B-vitamins.
Understanding and Application of Daptomycin-Susceptible Dose-Dependent Category for Enterococcus: A Mixed-Methods Study
Adema, Jennifer L. , Lake, Laurel N, Hogan, Breann M. , Tande, Aaron J. , Mara, Kristin C. , Eberly, Allison R. , Rivera, Christina G. , Tande, Aaron , Mara, Kristin C , Eberly, Allison R , Rivera, Christina G , Stevens, Ryan W. , Schuetz, Audrey N.

Mayo Clinic

Open Forum Infectious Diseases | January 12, 2022 | Volume: 9 | Issue: 1 | Pages: No page available

10.1093/ofid/ofab611 | PMID 35036465 Get It

Abstract Background In 2018, the Clinical Microbiology Laboratory at our institution adopted updated daptomycin Enterococcus–susceptible dose-dependent breakpoints. While the introduction of susceptible dose-dependent (SDD) was intended to guide practice toward optimal dosing, the understanding and application of daptomycin SDD breakpoints for enterococci were unknown. Methods This mixed-methods study combined a clinician survey with a retrospective pre–post prescribing analysis. An 8-question survey was distributed to infectious diseases (ID) and internal medicine (IM) clinicians. A retrospective chart review of hospitalized adults with infections due to Enterococcus spp. was conducted before (pre-SDD) and after (post-SDD) adoption of SDD reporting for enterococci. Results Survey response rates were 40 of 98 (41%) for IM and 22 of 34 (65%) for ID clinicians. ID clinicians scored significantly higher than IM clinicians in knowledge of SDD. Chart review of 474 patients (225 pre- vs 249 post-SDD) showed that daptomycin dosage following susceptibility testing was significantly higher post-SDD compared with pre-SDD (8.5 mg/kg vs 6.4 mg/kg; P &lt; .001) with no difference in empiric dosing (6.3 mg/kg vs 6.2 mg/kg; P = .67). Definitive daptomycin use varied between the pre- and post-SDD periods (35.1% vs 16.9%; P &lt; .001). Conclusions The survey revealed that ID clinicians placed more importance on and had more confidence in the SDD category over IM clinicians. SDD reporting was associated with a change in definitive daptomycin dosing. ID specialist involvement is recommended in the care of infections due to enterococci for which daptomycin is reported as SDD given their expertise.
Artificial intelligence in orthopedics: three strategies for deep learning with orthopedic specific imaging
Ko, Sunho , Pareek, Ayoosh , Martin, R. Kyle , Krych, Aaron J. , Krych, Aaron J , Ro, Du Hyun , Lu, Yining , Camp, Christopher L.

Mayo Clinic

Knee Surgery, Sports Traumatology, Arthroscopy | January 12, 2022 | Volume: 30 | Issue: 3 | Pages: 758-761

10.1007/s00167-021-06838-8 | PMID 35022826 Get It

The Effect of Bedside Rounds on Learning Outcomes in Medical Education: A Systematic Review
Ratelle, John T., Gallagher, Caitlyn N., Sawatsky, Adam P., Kashiwagi, Deanne T., Schouten, Will M., Gonzalo, Jed D., Beckman, Thomas J., West, Colin P., Ratelle, John T., Gallagher, Caitlyn N., Sawatsky, Adam P., Kashiwagi, Deanne T., Schouten, Will M., Gonzalo, Jed D., Beckman, Thomas J., West, Colin P.

Mayo Clinic

Academic Medicine | January 12, 2022 | Volume: 97 | Issue: 6 | Pages: 923-930

10.1097/acm.0000000000004586 | PMID 35020612 Get It

Purpose To determine if bedside rounds, compared with other forms of hospital ward rounds, improve learning outcomes in medical education. Method For this systematic review, the authors searched Ovid MEDLINE, Embase, and Scopus from inception through February 20, 2020. Experimental studies were included if they (1) compared bedside rounds to any other form of rounds in a hospital-based setting, and (2) reported a quantitative comparison of a learning outcome (e.g., learner reaction, knowledge, skills, behavior, health care delivery) among physicians-in-training (medical students, residents, fellows). Extraction elements were summarized using descriptive statistics and a narrative synthesis of design, implementation, and outcomes. Results Twenty studies met inclusion criteria, including 7 randomized trials. All studies involved resident physicians, and 11 also involved medical students. The design and implementation of bedside rounds varied widely, with most studies (n = 13) involving cointerventions (e.g., staff education, real-time order entry). Of the 15 studies that reported learner satisfaction, 7 favored bedside rounds, 4 favored the control, and 4 were equivocal. Of the 4 studies reporting an outcome of learners’ knowledge and skills, 2 favored bedside rounds and 2 were equivocal. Of the 8 studies that reported on learner behavior (e.g., bedside communication with patients), 5 favored bedside rounds, 1 favored the control, and 2 were equivocal. Finally, of the 14 studies that reported a health care delivery outcome (e.g., teamwork, rounding time), 8 favored bedside rounds and 6 were equivocal. Due to the high risk of bias and unexplained heterogeneity across studies, the overall strength of evidence was low. Conclusions In hospital-based settings, learners’ satisfaction with bedside rounds is mixed. However, bedside rounds appear to have a positive effect on learner behavior and health care delivery. Given their potential value, additional research is needed to identify barriers to and facilitators of educationally successful bedside rounds.
Comment on: Pet husbandry as a risk factor for colonization or infection with MDR organisms: a systematic meta-analysis
El‐Qushayri, Amr Ehab , Ghozy, Sherief , Ghozy, Sherief

Mayo Clinic

Journal of Antimicrobial Chemotherapy | January 12, 2022 | Volume: 77 | Issue: 7 | Pages: 2042-2042

10.1093/jac/dkac012 | PMID 35134945 Get It